Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DFJ DragonFund is a venture capital firm focused primarily on investing in China-centric early- and middle-stage technology companies. The firm was established in 2006 as a joint venture between Draper Fisher Jurvetson and DragonVenture, and has been described as the exclusive China affiliate of DFJ. Publicly available profiles indicate it manages multiple USD and RMB funds and operates from Silicon Valley with offices in Shanghai, and in some sources Beijing. Although some databases list occasional investments in healthcare-related companies, DFJ DragonFund is not itself a life science, biotech, pharma, or healthcare operating company; it is an investor.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DFJ DragonFund.